Editas Medicine, Inc. EDIT
Set alert
2.57 USD -0.10 -3.75%
At close · Nov 2
2.59 +0.02 +0.67%
After hours · Nov 2, 4:13 PM ET
2.55 Day range 2.78
1.66 52-week range 3.94
- YTD
- +25.37%
- 1 year
- -16.56%
- Open
- 2.71
- Prev close
- 2.67
- Mkt cap
- 394.70M
- Vol
- 1.24M
- Avg vol
- 2.69M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.55
- High
- 2.78
- Forward P/E
- -0.53
- Beta
- 2.01
- Short ratio
- 6.70
- Inst. own
- 70.94%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.60
- 200-d avg
- 4.55
- 1y target
- 3.67
15m chart
Built from the cached five-day intraday bars.
Signals (26)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 1:40 PM | 6 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 7 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 7 hours ago |
| SMA: Bearish | Nov 2, 10:40 AM | 9 hours ago |
| SMA: Bearish | Nov 2, 10:40 AM | 9 hours ago |
| SMA: Bullish | Nov 2, 9:55 AM | 10 hours ago |
| SMA: Bullish | Oct 30, 3:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:40 PM | 4 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 9:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:55 PM | 5 days ago |
| RSI: Overbought | Oct 28, 3:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 5 days ago |
| RSI: Overbought | Oct 28, 10:55 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 6 days ago |
| SMA: Bearish | Oct 27, 3:25 PM | 6 days ago |
| SMA: Bullish | Oct 27, 2:55 PM | 6 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 6 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 6 days ago |
| RSI: Overbought | Oct 27, 1:25 PM | 6 days ago |
| SMA: Bearish | Oct 27, 1:10 PM | 6 days ago |
Financial health
Altman Z-Score
-8.05 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E -1.1×
FY 2016 5y median -2.8× FY 2025
P/S 4.5×
FY 2016 5y median 9.9× FY 2025
P/B 6.7×
FY 2016 5y median 2.2× FY 2025
P/FCF -1.1×
FY 2016 5y median -3.4× FY 2025
EV/EBITDA -0.8×
FY 2016 5y median -2.4× FY 2025
EV/Sales 2.8×
FY 2016 5y median 8.9× FY 2025
FCF Yield -91.2%
FY 2016 5y median -29.8% FY 2025
Profitability
Gross Margin 100.0%
FY 2016 5y median 80.2% FY 2025
Operating Margin -245.2%
FY 2016 5y median -756.1% FY 2025
Net Margin -395.0%
FY 2016 5y median -733.7% FY 2025
ROE -586.6%
FY 2016 5y median -61.1% FY 2025
ROIC -65.6%
FY 2016 5y median -48.6% FY 2025
ROA -85.8%
FY 2016 5y median -42.9% FY 2025
Growth (YoY)
Revenue 25.4%
FY 2016 FY 2025
Operating Income 60.4%
FY 2016 FY 2025
EPS (diluted) 37.5%
FY 2016 FY 2025
Free Cash Flow 24.3%
FY 2016 FY 2025
Financial Health
Current Ratio 3.5×
FY 2016 5y median 5.4× FY 2025
Quick Ratio 3.5×
FY 2016 5y median 5.4× FY 2025
Debt / Equity 2.8×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -16.1×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31